Which androgen receptor inhibitor drugs treat prostatic neoplasms?

pharmaranks lists 3 Androgen Receptor Inhibitor products used for prostatic neoplasms, per NIH RxClass drug-classification data — each independently rated and ranked above.

How are these ranked?

By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.

Best Androgen Receptor Inhibitor for prostatic neoplasms

Top-rated pick: Xtandi — pharmaranks score 72/100, the highest of the 3 Androgen Receptor Inhibitor drugs used for prostatic neoplasms, ranked by our independent FDA recall-safety score. Compare them with all treatments for prostatic neoplasms or the full Androgen Receptor Inhibitor class. Not medical advice — always consult a professional.

Quick answer: Of the 3 androgen receptor inhibitor drugs we rate for prostatic neoplasms, 1 is available as lower-cost generics, and most are tablet. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for prostatic neoplasms; the right choice depends on your situation, so confirm it with your prescriber.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Other drug classes for prostatic neoplasms

Best estrogen Best 5-alpha reductase inhibitor Best topoisomerase inhibitor

Top androgen receptor inhibitor for prostatic neoplasms: 1. Xtandi · 2. Casodex · 3. Enzalutamide

Best-rated Androgen Receptor Inhibitor for prostatic neoplasms, ranked by pharmaranks score
#	Drug	Rating	Type	Form	Generic?	Pharmacy pays
1	Xtandi	72/100	Prescription	Tablet	No data	—	View →
2	Casodex	70/100	Prescription	Tablet	Generic	$12	View →
3	Enzalutamide	68/100	Prescription	Tablet	No data	—	View →

Full ranking · 3 drugs

#1 of 3 in Androgen Receptor Inhibitor

xtandi

PrescriptionFDA-sourced

72/100

Xtandi (Enzalutamide) is an androgen receptor inhibitor used to treat Prostatic Neoplasms.

(4 data points)

androgen receptor inhibitorprostatic neoplasms

Price varies

View details →

#2 of 3 in Androgen Receptor Inhibitor

casodex

PrescriptionFDA-sourced

70/100

Casodex (Bicalutamide) is an androgen receptor inhibitor used to treat Prostatic Neoplasms.

(1 data points)

androgen receptor inhibitorprostatic neoplasms

Pharmacy pays

~$12.17 /30

View details →

#3 of 3 in Androgen Receptor Inhibitor

enzalutamide

PrescriptionFDA-sourced

68/100

Enzalutamide is an androgen receptor inhibitor used to treat Prostatic Neoplasms.

(23 data points)

androgen receptor inhibitorprostatic neoplasms

Price varies

View details →

Frequently asked

What is the best androgen receptor inhibitor for prostatic neoplasms?: By our independent recall-safety rating — not an efficacy measure — xtandi ranks highest among Androgen Receptor Inhibitor drugs used for prostatic neoplasms. Always consult a professional.
Which androgen receptor inhibitor drugs treat prostatic neoplasms?: pharmaranks lists 3 Androgen Receptor Inhibitor products used for prostatic neoplasms, per NIH RxClass drug-classification data — each independently rated and ranked above.
How are these ranked?: By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.